Simple cord milking procedure could save preterm Infants' lives

NCT ID NCT06240715

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now This study
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jul 13, 2026 · Last updated Jul 14, 2026 · Updated 1 time

Summary

This trial compares two ways of managing the umbilical cord right after birth in preterm infants (30-34 weeks) who are not vigorous. One method, umbilical cord milking, involves pushing blood from the cord toward the baby before clamping. The other is early cord clamping. The study aims to see if milking reduces the chance of death while the baby is still in the hospital. About 800 infants will take part across multiple hospitals.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
Umbilical cord milking (procedure)
What this could lead to
If effective, this simple, quick procedure could lower the risk of death and complications in vulnerable preterm infants who are not vigorous at birth.
What could go wrong
The trial is still recruiting and results are not yet known. The procedure may not reduce mortality and could carry risks such as bleeding in the brain or infection.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

About 800 people

The number the study aims to enrol. It can still change while the study runs.

Started

Jul 2024

Expected to finish

Mar 2027

An estimate. End dates often move.

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

0 to 10 minutes

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Preterm infants born between 30 0/7 weeks to 34 6/7 weeks of gestation * Non-vigorous at birth Exclusion Criteria: * Infants with congenital malformation * Major chromosomal abnormalities * Complete placental abruption/cutting through the placenta at the time of delivery * Cord conditions (umbilical knots, inadequate cord length, cord rupture, non-reducible nuchal cord) * Mono-chorionic twins, * Twins with no information on amnion/chorion * Multiple gestation \>2

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Infant death are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

How to take part

Only the study team decides who joins. These are the ways to reach them.

  1. The places running it

    9 sites. The list below names each one and where it is.

  2. The official record

    ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.

    Open the record ↗

  3. A doctor treating you

    A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.

Contacts and locations

Locations

  • Daga Memorial Woman and Children Hospital

    RECRUITING

    Nagpur, MS, 440002, India

  • Government Medical College

    NOT_YET_RECRUITING

    Chandrapur, Maharashtra, 442401, India

  • Government Medical College and Hospital

    NOT_YET_RECRUITING

    Nagpur, MS, 440009, India

  • Indira Gandhi Government Medical College & Hospital

    NOT_YET_RECRUITING

    Nagpur, Maharashtra, 440018, India

  • KLE Academy of Higher Education and Research (Deemed-to-be-University) Jawaharlal Nehru Medical College

    NOT_YET_RECRUITING

    Belagavi, Karnataka, 590010, India

  • Mahatma Gandhi Institute of Medical Sciences/ Kasturba Hospital

    NOT_YET_RECRUITING

    Wardha, MS, 442102, India

  • Osmania Medical College, Niloufer Hospital

    RECRUITING

    Hyderabad, Telangana, 500004, India

  • Sawai Man Singh Medical College

    RECRUITING

    Jaipur, Rajasthan, 302004, India

  • Yashwantrao Chavan Memorial Hospital

    NOT_YET_RECRUITING

    Pune, Maharashtra, 411018, India

More trials for these conditions

Other studies related to the condition(s) this trial covers.